marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Phio Pharmaceuticals Corp. Balance Sheet 2011-2024 | PHIO
Annual Balance Sheet Phio Pharmaceuticals Corp.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-11.6 M | -23.8 M | -14 M | -6.42 M | -14.9 M | -3.58 M | -12.9 M | -5.12 M | -8.5 M | -11.4 M | -5.12 M | 31 K | |
Long Term Debt |
- | 35 K | 170 K | 231 K | - | - | - | - | - | - | - | - | 500 K |
Long Term Debt Current |
35 K | 135 K | 125 K | 116 K | 107 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 526 K | 411 K | - | - | - | - | 5.11 M | 7.92 M | 9.75 M | 505 K |
Total Current Liabilities |
1.63 M | 1.94 M | 3.07 M | 2.2 M | 1.88 M | 1.74 M | 2.26 M | 2.54 M | 2.27 M | 1.33 M | 2.08 M | 1.68 M | - |
Total Liabilities |
1.63 M | 1.97 M | 3.24 M | 2.72 M | 2.29 M | 1.74 M | 2.26 M | 2.54 M | 2.27 M | 6.44 M | 10 M | 11.4 M | 2.28 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | 47 K | 118 K | 491 K | 816 K |
Retained Earnings |
-139 M | -128 M | -117 M | -104 M | -94.8 M | -85.9 M | -78.6 M | -66.1 M | -57.1 M | -46.9 M | -38.1 M | -17.2 M | -4.28 M |
Total Assets |
9.36 M | 12.8 M | 25.2 M | 15.7 M | 8.04 M | 15.3 M | 4.1 M | 13.4 M | 11.2 M | 9.19 M | 14.9 M | 5.59 M | 1.69 M |
Cash and Cash Equivalents |
8.49 M | 11.8 M | 24.1 M | 14.2 M | 6.93 M | 14.9 M | 3.58 M | 12.9 M | 5.12 M | 8.5 M | 11.4 M | 5.13 M | 503 K |
Book Value |
7.73 M | 10.8 M | 21.9 M | 13 M | 5.75 M | 13.6 M | 1.83 M | 10.9 M | 8.89 M | 2.74 M | 4.94 M | -5.84 M | -587 K |
Total Shareholders Equity |
7.73 M | 10.8 M | 21.9 M | 13 M | 5.75 M | 13.6 M | 1.83 M | 10.9 M | 8.89 M | 2.74 M | 4.94 M | -5.84 M | -587 K |
All numbers in USD currency
Quarterly Balance Sheet Phio Pharmaceuticals Corp.
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | 35 K | 70 K | 104 K | 138 K | 170 K | - | - | - | 231 K | 231 K | 231 K | 231 K | - | - | - | 411 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | 2.33 M | 2.39 M | 2.4 M | 1.97 M | 2.26 M | 3.14 M | 2.71 M | 3.24 M | 2.7 M | 2.81 M | 2.46 M | 2.72 M | 2.72 M | 2.72 M | 2.72 M | 2.29 M | 2.29 M | 2.29 M | 2.29 M | 1.74 M | 1.74 M | 1.74 M | 1.74 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.08 M | 1.34 M | 1.51 M | 1.96 M | 1.71 M | 1.71 M | 1.71 M | 1.71 M | 2.28 M | 2.28 M | 2.28 M | 2.28 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 47 K | 47 K | 47 K | 47 K | 118 K | 118 K | 118 K | 118 K | 491 K | 491 K | 491 K | 491 K | 816 K | 816 K | 816 K | 816 K |
Retained Earnings |
-145 M | -143 M | -141 M | -139 M | -137 M | -135 M | -132 M | -128 M | -126 M | -122 M | -120 M | -117 M | -113 M | -110 M | -107 M | -104 M | -104 M | -104 M | -104 M | -94.8 M | -94.8 M | -94.8 M | -94.8 M | -85.9 M | -85.9 M | -85.9 M | -85.9 M | -78.6 M | -78.6 M | -78.6 M | -78.6 M | -66.1 M | -66.1 M | -66.1 M | -66.1 M | -57.1 M | -57.1 M | -57.1 M | -57.1 M | -46.9 M | -46.9 M | -46.9 M | -46.9 M | -38.1 M | -38.1 M | -38.1 M | - | 17.2 M | 15.4 M | 13.8 M | - | - | - | - | - |
Total Assets |
5.86 M | 5.3 M | 6.85 M | 9.36 M | 9.54 M | 12.3 M | 9.71 M | 12.8 M | 15.8 M | 20.1 M | 22.2 M | 25.2 M | 27.9 M | 31.7 M | 33.9 M | 15.7 M | 15.7 M | 15.7 M | 15.7 M | 8.04 M | 8.04 M | 8.04 M | 8.04 M | 15.3 M | 15.3 M | 15.3 M | 15.3 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 9.19 M | 9.19 M | 9.19 M | 9.19 M | 14.9 M | 14.9 M | 14.9 M | 14.9 M | 5.59 M | 5.59 M | 5.59 M | 5.59 M | 1.69 M | 1.69 M | 1.69 M | 1.69 M |
Cash and Cash Equivalents |
5.39 M | 4.7 M | 6.48 M | 8.49 M | 8.41 M | 11.3 M | 9.04 M | 11.8 M | 14.5 M | 18 M | 20.5 M | 24.1 M | 26.5 M | 29.4 M | 32.7 M | 14.2 M | 14.2 M | 14.2 M | 14.2 M | 6.93 M | 6.93 M | 6.93 M | 6.93 M | 14.9 M | 3.24 M | 5.32 M | 2.61 M | 3.58 M | 5.42 M | 3.58 M | 3.58 M | 12.9 M | 12.9 M | 12.9 M | 12.9 M | 5.12 M | 5.12 M | 5.12 M | 5.12 M | 8.5 M | 8.5 M | 8.5 M | 8.5 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 5.13 M | 5.13 M | 5.13 M | 5.13 M | 503 K | 503 K | 556 K | 556 K |
Book Value |
- | - | - | - | 7.21 M | 9.9 M | 7.31 M | 10.8 M | 13.5 M | 17 M | 19.5 M | 21.9 M | 25.2 M | 28.8 M | 31.4 M | 13 M | 13 M | 13 M | 13 M | 5.75 M | 5.75 M | 5.75 M | 5.75 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 4.1 M | 4.1 M | 4.1 M | 4.1 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 9.19 M | 9.19 M | 9.19 M | 9.19 M | 12.9 M | 13.6 M | 13.4 M | 13 M | 3.89 M | 3.89 M | 3.89 M | 3.89 M | -587 K | -587 K | -587 K | -587 K |
Total Shareholders Equity |
4.95 M | 3.77 M | 5.6 M | 7.73 M | 7.21 M | 9.9 M | 7.31 M | 10.8 M | 13.5 M | 17 M | 19.5 M | 21.9 M | 25.2 M | 28.8 M | 31.4 M | 13 M | 13 M | 13 M | 13 M | 5.75 M | 5.75 M | 5.75 M | 5.75 M | 13.6 M | 13.6 M | 13.6 M | 13.6 M | 1.83 M | 1.83 M | 1.83 M | 1.83 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 8.89 M | 8.89 M | 8.89 M | 8.89 M | 2.74 M | 2.74 M | 2.74 M | 2.74 M | 4.94 M | 4.94 M | 4.94 M | 4.94 M | -5.84 M | -5.84 M | -5.84 M | -5.84 M | -587 K | -587 K | -587 K | -587 K |
All numbers in USD currency